They have identified a novel homozygous CISD2 mutation in a patient with “classical” WFS1 phenotype, which is childhood-onset DM and optic atrophy without peptic ulcers or defective platelet aggregation, as reported previously in CISD2 mutation carriers. The gene discussed is WFS1; the disease is optic atrophy.